# Progress Report 4 — Final System Integration & Polish

**Student:** Ty Parker  
**Course:** INFO 603/404 Biological Data Management  
**Professor:** Jake Y. Chen  
**Date:** April 27, 2026  

---

## Phase 4 Objectives

- Expand to 4 disease contexts (add Lung Adenocarcinoma)
- Build Cross-Disease Comparison page
- Build AI Results Interpreter with Groq LLM integration
- Complete visual overhaul with professional design system
- Create About page addressing LOI requirements and citations
- Verify reproducibility
- Finalize documentation

## Completed Work

### 4th Disease Context: Lung Adenocarcinoma (LUAD)

Added `luad.json` configuration covering EGFR, ALK, and KRAS biomarkers with:
- cBioPortal study: `luad_tcga_pan_can_atlas_2018`
- EFO disease ID: `EFO_0000571`
- 5 interaction rules (EGFR T790M resistance, ALK rearrangement, KRAS co-mutations, PD-L1 immunotherapy, EGFR+ALK mutual exclusivity)
- Standard therapies: EGFR TKI, ALK inhibitor, immunotherapy, chemotherapy

The system now supports 4 complete disease contexts without any code changes — demonstrating config-driven generalizability.

### Cross-Disease Comparison Page (`/compare`)

Built a side-by-side comparison interface that:
- Allows selection of 1–4 disease contexts via checkboxes
- Fires parallel API calls to `/api/agent` for each selected context
- Displays results in a responsive grid: cohort data, evidence tables, predictions with confidence badges, benchmarked leads with tier indicators
- Generates a Cross-Context Summary table comparing biomarker counts, prediction counts, lead counts, top tier, and top composite score
- Includes JSON export of all results for downstream analysis

This page is the strongest demonstration of config-driven reusability — one query produces meaningfully different results across HR+/HER2−, TNBC, CRC, and LUAD.

### AI Results Interpreter (`/interpret`)

Built a Groq LLM-powered interpretation system that:
- Loads recent runs from Supabase via `/api/history`
- Fetches full run details from `/api/run/[runId]` including all tool call outputs
- Extracts compact data summaries (cohort, evidence, predictions, leads)
- Sends summaries to Groq (llama-3.3-70b-versatile) with a heavily constrained biomedical system prompt
- Generates initial interpretation citing specific data points (mutation frequencies, confidence scores, tier classifications)
- Supports multi-turn follow-up questions with conversation memory
- Supports comparison mode — select two runs for cross-disease interpretation
- Includes clear disclaimer: "LLM-assisted interpretation — the scientific pipeline remains fully deterministic"

The LLM is a Tier-2 interpretation layer only. It never influences predictions, scores, or pipeline outputs. This satisfies the LOI requirement for Groq integration while maintaining the deterministic integrity of the scientific pipeline.

**API Route:** `/api/interpret` — accepts run summaries + question, builds data-grounded system prompt, calls Groq with temperature 0.3, returns interpretation.

### About Page (`/about`)

Created a comprehensive About page addressing all LOI requirements:
- Scientific question (quoted directly from LOI)
- Problem statement
- Design boundaries (no duplication, no new algorithms, no hypothesis-driven claims, database as output, agentic AI component)
- Key citations: BioAgents (Mehandru et al., 2025), Drug Target Review (2024), CIViC MCP (Schimmelpfennig et al., 2025), Reactome (Ragueneau et al., 2025), Zhou et al. (2025)
- All 6 integrated data sources with descriptions
- Success criteria with verification status

### Design System Overhaul

Implemented a professional design system across all 6 pages:
- **Typography:** JetBrains Mono (data/labels), Source Sans 3 (body text)
- **Color system:** CSS variables — cyan (#06b6d4), blue (#3b82f6), purple (#8b5cf6), teal (#14b8a6), amber (#f59e0b), green (#22c55e), rose (#f43f5e)
- **Shared components:** `globals.css` with nav, card, table, pill, footer, and animation classes
- **Consistent navigation:** ATRP logo with pulsing indicator, 6-page nav with active states
- **Animations:** Staggered fadeInUp on result sections, gradient text shift on hero title
- **Hero section:** Grid pattern overlay, gradient background, data source badges

All pages share the same `globals.css` and nav pattern, creating a cohesive professional application.

### Pages Summary

| Page | Route | Purpose |
|------|-------|---------|
| Home | `/` | Primary query interface, run agent, view full results |
| About | `/about` | Scientific question, citations, LOI requirements |
| Compare | `/compare` | Side-by-side multi-disease context analysis |
| Interpret | `/interpret` | LLM-powered interpretation of run results |
| Methods | `/methods` | Data sources, scoring formulas, architecture, FAIR |
| History | `/history` | Supabase-backed run audit log |

## Reproducibility Verification

Reproducibility was verified by running identical queries across multiple sessions. HR+/HER2- with query "Predict therapy response and benchmark leads" produced identical results: PIK3CA confidence 1.00 (high), ESR1 confidence 0.30 (low), RB1 confidence 0.60 (moderate), with PIK3CA as Tier 1 (0.620) across all runs. This is expected by design — the pipeline uses deterministic heuristics with no stochastic components. The only source of variation is upstream API data freshness, but the heuristic computations are stable given identical inputs.

## FAIR Compliance (Final)

| Principle | Implementation |
|---|---|
| Findable | Unique run IDs, organized repo, Supabase-indexed runs, public GitHub, searchable history page |
| Accessible | All 5 external APIs are open (no keys), public GitHub repo, live Vercel deployment, comprehensive Methods page |
| Interoperable | JSON throughout, REST + GraphQL APIs, EFO ontology IDs, modular config-driven architecture, PostgreSQL storage |
| Reusable | Config-driven (add diseases via JSON only), documented workflows, full provenance, transparent scoring, export functionality, disease context guide |

## Changes from Phase 3

| Component | Phase 3 | Phase 4 |
|---|---|---|
| Disease contexts | 3 (HR+/HER2−, TNBC, CRC) | 4 (+LUAD) |
| Pages | 4 (Home, Methods, History, Run Detail) | 6 (+About, Compare, Interpret) |
| LLM integration | None | Groq llama-3.3-70b-versatile for interpretation |
| Design | Functional dark theme | Professional design system with shared CSS |
| Navigation | Basic links | Branded nav with logo, active states, About link |
| Cross-disease analysis | Not available | Full comparison page with parallel execution |
| Documentation | Methods page | Methods + About page + disease context guide |

## LOI Success Criteria Assessment

| Criterion | Status | Evidence |
|---|---|---|
| Reproducibility | ✅ Verified | Deterministic heuristics, identical outputs confirmed, stored provenance |
| Transparency | ✅ Implemented | Full reasoning trace per run, evidence table with source attribution, scored dimensions |
| Generalizability | ✅ Demonstrated | 4 disease contexts, same pipeline, config-driven, Compare page proves it |
| Data Management | ✅ Complete | 6-table Supabase schema, tool call logging, evidence items, reports with provenance |

## Technical Stack (Final)

- **Frontend:** Next.js 16 (JavaScript, App Router)
- **Styling:** Custom CSS design system (globals.css)
- **Database:** Supabase (PostgreSQL, 6 tables)
- **External APIs:** cBioPortal, OpenTargets, CIViC, DGIdb, Reactome
- **LLM:** Groq (llama-3.3-70b-versatile) — interpretation only
- **Deployment:** Vercel
- **Repository:** github.com/ParkerTy/AgenticTherapyResponsePredictor

## Deployment

Live URL: https://agentic-therapy-response-predictor.vercel.app